Announcements Trials
Browse Landscape

Phase

Phase 2 33Phase NA 11Phase 3 7Phase 1 6Phase 1/2 5Phase 2/3 4Phase EARLY_PHASE1 3Phase 4 2

Status

Unknown 4Withdrawn 1Terminated 1Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Carcinoma, Hepatocellular 3Neoplasms 1Liver Neoplasms 1Hepatoblastoma 1

Interventions

Cisplatin 20Docetaxel 19Capecitabine 19Oxaliplatin 14Drug Therapy 14Cyclophosphamide 14Paclitaxel 13Fluorouracil 12Radiotherapy 11apatinib 9Gemcitabine 9Doxorubicin 9Decitabine 9Methotrexate 8Epirubicin 8Carboplatin 8sintilimab 6Etoposide 6camrelizumab 5anlotinib 5XELOX 5Sorafenib 5Radiation 5Pemetrexed 5Neoadjuvant Therapy 5Leucovorin 5Idarubicin 5Dexamethasone 5Cytarabine 5Busulfan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Unknown × lenvatinib × Clear all
NCT05250843 2023-10-13

TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC

Third Affiliated Hospital, Sun Yat-Sen University

Phase 2/3 Unknown
90 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05322187 2022-04-11

sPLENTY-pc

RenJi Hospital

Phase 2/3 Unknown
15 enrolled
Gastrointestinal

Liver Neoplasms, Neoplasms, Hepatoblastoma

NCT04319484 2020-03-24

LLTHVV

RenJi Hospital

Phase 2/3 Unknown
108 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04168944 2019-11-19

Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma

RenJi Hospital

Phase 2/3 Unknown
108 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡